Replay available

Bonesupport Holding AB (publ) (BONEX) Q4 2025 Earnings Call

Bonesupport Holding AB (publ) (STO: BONEX) Q4 2025 earnings conference call, held 2026-02-24. Replay captured from the company's public earnings webcast.

Tue, February 24, 2026 at 4:00 AMendedReplay
Bonesupport Holding AB (publ) (BONEX) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Torbjörn Sjöld

CEO of Bone Support

Håkan Johansson

CFO of Bone Support

Eric Castle

Analyst at Danske Bank

Oscar Bergman

Analyst at Red Eye

Victor Sundberg

Analyst at Nordia

Stan Gustafson

Analyst at AVG Sundal Collier

Matthias Vadsten

Analyst at SEB

Replay transcript excerpt

Welcome to Bone Support Year-End Report 2025 presentation. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to CEO Torbjorn Skuld and CFO Håkon Johansson. Please go ahead. Thank you, operator, and welcome everyone to Bone Support's Q4 and full year 2025 results call. My name is Torbjörn Sjöld. I'm the CEO of Bone Support, and with me here today is our CFO, Håkan Johansson, and together we will use the next 25 minutes to guide you through the Q4 presentation and then open the line for questions. But before we start the presentation, I would like to draw your attention to the disclaimers covering any forward-looking statements that we will make today. So let's look at the financial and operational highlights from the quarter. Q4 was another strong quarter with solid execution across the business. Net sales came in at 313 million SEC, corresponding to a growth of 22% versus Q4 2024. Sales growth at constant exchange rates was 36%, showing that there was a continued strong currency impact on our figures for the quarter. Our adjusted operating results, excluding incentive program effects, was 81 million SEC, corresponding to an adjusted operating margin of 26%. Reported operating results was 82 million SEC, and we saw solid cash generation with operating cash flows reaching 54 million SEC. We continue to see strong traction for Ceramat-G in the U.S., where both new accounts and increased use among current users contributed to the strong progress. Therma G sales in the US reached 207 million SEC for the quarter, compared to 154 million SEC in the same period the year be...

More from Bonesupport Holding Ab